ProfileGDS4718 / 231593_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 19% 33% 21% 28% 17% 17% 11% 37% 24% 16% 18% 18% 24% 21% 10% 11% 14% 21% 17% 27% 25% 19% 20% 15% 22% 17% 19% 13% 21% 16% 18% 13% 24% 12% 14% 19% 17% 25% 21% 14% 25% 10% 10% 19% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1371319
GSM549102patient 115, normal, homogenized [OPG study]4.6950633
GSM549104patient 119, normal, homogenized [OPG study]4.1446921
GSM549108patient 138, normal, homogenized [OPG study]4.5118428
GSM549119patient 077, normal, homogenized [OPG study]4.0244117
GSM549133patient 032, cancer, homogenized [OPG study]3.980117
GSM549139patient 042, cancer, homogenized [OPG study]3.8052811
GSM549099patient 107, normal, homogenized [OPG study]4.8851837
GSM549109patient 139, normal, homogenized [OPG study]4.3272924
GSM549110patient 046, normal, homogenized [OPG study]3.9974616
GSM549114patient 063, normal, homogenized [OPG study]4.0509618
GSM549122patient 082, normal, homogenized [OPG study]4.093818
GSM549134patient 033, cancer, homogenized [OPG study]4.3043524
GSM549136patient 036, cancer, homogenized [OPG study]4.1205521
GSM549140patient 044, cancer, homogenized [OPG study]3.741710
GSM549111patient 047, normal, homogenized [OPG study]3.7976511
GSM549113patient 057, normal, homogenized [OPG study]3.8807914
GSM549132patient 031, cancer, homogenized [OPG study]4.1826521
GSM549137patient 038, cancer, homogenized [OPG study]4.023317
GSM549142patient 047, cancer, homogenized [OPG study]4.5207827
GSM549100patient 110, normal, homogenized [OPG study]4.3339825
GSM549107patient 135, normal, homogenized [OPG study]4.0907919
GSM549115patient 068, normal, homogenized [OPG study]4.0864820
GSM549116patient 072, normal, homogenized [OPG study]3.9485515
GSM549120patient 078, normal, homogenized [OPG study]4.1994122
GSM549131patient 030, cancer, homogenized [OPG study]3.9772117
GSM549118patient 074, normal, homogenized [OPG study]4.1221219
GSM549129patient 027, cancer, homogenized [OPG study]3.8869213
GSM549123patient 088, normal, homogenized [OPG study]4.1814721
GSM549124patient 006, cancer, homogenized [OPG study]4.0410816
GSM549126patient 015, cancer, homogenized [OPG study]4.0762618
GSM549128patient 025, cancer, homogenized [OPG study]3.882413
GSM549103patient 117, normal, homogenized [OPG study]4.3562624
GSM549117patient 073, normal, homogenized [OPG study]3.8490412
GSM549138patient 041, cancer, homogenized [OPG study]3.9093214
GSM549141patient 045, cancer, homogenized [OPG study]4.0521919
GSM549130patient 028, cancer, homogenized [OPG study]4.0311117
GSM549101patient 111, normal, homogenized [OPG study]4.3387925
GSM549105patient 128, normal, homogenized [OPG study]4.1856421
GSM549106patient 134, normal, homogenized [OPG study]3.881114
GSM549112patient 048, normal, homogenized [OPG study]4.3107725
GSM549125patient 011, cancer, homogenized [OPG study]3.7921910
GSM549127patient 024, cancer, homogenized [OPG study]3.770210
GSM549135patient 035, cancer, homogenized [OPG study]4.0431519